CompanyBristol-Myers Squibb Pharma EEIG
ATC codeL01XL08
EU authorised2022-04-04
· 4 yr ago
Flags
—
EMA EPAR
Evidence dossier ↗
Breyanzi CONFIRMED
lisocabtagene maraleucel · DLBCL 3L
Current stage: 6 · first detected 2026-06-25
Also known as: breyanzi
Nordic decisions
| Country | Body | Verdict | Date | Source |
|---|---|---|---|---|
| Danmark | Medicinrådet | Anbefalet | 2025-03-26 | link |
| Sverige | NT-rådet | kan användas | 2024-06-14 | link |
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| No status history. | ||||